[go: up one dir, main page]

NO20032097D0 - Gj¶ravledet vaksine mot IPNV - Google Patents

Gj¶ravledet vaksine mot IPNV

Info

Publication number
NO20032097D0
NO20032097D0 NO20032097A NO20032097A NO20032097D0 NO 20032097 D0 NO20032097 D0 NO 20032097D0 NO 20032097 A NO20032097 A NO 20032097A NO 20032097 A NO20032097 A NO 20032097A NO 20032097 D0 NO20032097 D0 NO 20032097D0
Authority
NO
Norway
Prior art keywords
vaccines
ipnv
vaccine
polypeptide
disclosed
Prior art date
Application number
NO20032097A
Other languages
English (en)
Other versions
NO333007B1 (no
NO20032097L (no
Inventor
William Thomas Melvin
Suzanne Breeman
Marie Beagley Labus
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0027644A external-priority patent/GB0027644D0/en
Priority claimed from GB0030765A external-priority patent/GB0030765D0/en
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Publication of NO20032097D0 publication Critical patent/NO20032097D0/no
Publication of NO20032097L publication Critical patent/NO20032097L/no
Publication of NO333007B1 publication Critical patent/NO333007B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO20032097A 2000-11-11 2003-05-09 Fremgangsmate for a fremstille bivalent vaksine mot IPNV, ekspresjonsvektor, vertcelle og bivalent vaksine. NO333007B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0027644A GB0027644D0 (en) 2000-11-11 2000-11-11 Fish vaccine
GB0030765A GB0030765D0 (en) 2000-12-14 2000-12-14 Fish vaccine
PCT/GB2001/004986 WO2002038770A1 (en) 2000-11-11 2001-11-12 Yeast derived vaccine against ipnv

Publications (3)

Publication Number Publication Date
NO20032097D0 true NO20032097D0 (no) 2003-05-09
NO20032097L NO20032097L (no) 2003-07-10
NO333007B1 NO333007B1 (no) 2013-02-18

Family

ID=26245278

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032097A NO333007B1 (no) 2000-11-11 2003-05-09 Fremgangsmate for a fremstille bivalent vaksine mot IPNV, ekspresjonsvektor, vertcelle og bivalent vaksine.

Country Status (8)

Country Link
EP (1) EP1334197B1 (no)
AT (1) ATE494377T1 (no)
AU (1) AU2002212555A1 (no)
CA (1) CA2428027C (no)
DE (1) DE60143810D1 (no)
DK (1) DK1334197T3 (no)
NO (1) NO333007B1 (no)
WO (1) WO2002038770A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60227498D1 (de) * 2001-03-23 2008-08-21 Advanced Bionutrition Corp Abgabe von mitteln zur krankheitskontrolle in aquakultur unter verwendung von bioaktive proteine enthaltender hefe
TWI350310B (en) 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
DE602004028029D1 (en) * 2003-10-07 2010-08-19 Ingrid Dheur Rwendung
CA2615139A1 (en) * 2004-10-01 2006-04-13 Michel Thiry Piscirickettsia salmonis antigens and use thereof
CA2673355A1 (en) 2006-12-20 2008-11-20 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
WO2008077413A1 (es) * 2006-12-22 2008-07-03 Soluciones Biotecnologicas Innovacion Ltda Vacunas adn en peces
WO2009077577A2 (en) 2007-12-19 2009-06-25 Schering-Plough Limited Vaccine antigens from piscirickettsia salmonis
CN104884084B (zh) 2012-09-26 2018-05-22 Fvg有限公司 鱼用亚单位浸泡疫苗
JP7186401B2 (ja) * 2017-02-28 2022-12-09 フエー・イー・ベー・フエー・ゼツト・ウエー タンパク質の経口送達のための手段及び方法
CN115804837B (zh) * 2022-02-24 2023-06-20 中国水产科学研究院黑龙江水产研究所 一种传染性胰脏坏死病佐剂疫苗及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus

Also Published As

Publication number Publication date
AU2002212555A1 (en) 2002-05-21
ATE494377T1 (de) 2011-01-15
EP1334197B1 (en) 2011-01-05
DE60143810D1 (de) 2011-02-17
WO2002038770A1 (en) 2002-05-16
CA2428027C (en) 2012-09-11
EP1334197A1 (en) 2003-08-13
CA2428027A1 (en) 2002-05-16
NO333007B1 (no) 2013-02-18
NO20032097L (no) 2003-07-10
DK1334197T3 (da) 2011-04-04

Similar Documents

Publication Publication Date Title
EA200801221A1 (ru) Вирусные вакцины, полученные из клеток, с низкими уровнями остаточной клеточной днк
MXPA05009096A (es) Metodo de cultivo celular libre de animal.
BR9205771A (pt) Vetor de vírus recombinantes e processo para a fabricaçao do mesmo
DK0633929T3 (da) Fremgangsmåde til in vitro proliferation af dendritcelleforstadier og deres anvendelse til at producere immunogener
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
ATE429246T1 (de) Verfahren zur herstellung von biologischen produkten in protein-freiem kultur
CY1110716T1 (el) Πολλαπλασιασμος ιων εντος κυτταροκαλλιεργειας
UA93855C2 (ru) Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе
NZ589755A (en) Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same
EP1054683A4 (en) MODIFIED HEAT SHOCK PROTEIN / PEPTIDEANT COMPLEX
CA2505942A1 (en) West nile virus vaccine
NO20032097D0 (no) Gj¶ravledet vaksine mot IPNV
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
Stuart et al. Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea
DE60218327D1 (de) Inaktivierte immunogene bakterielle ganzzell-zusammensetzungen
EE200200157A (et) Vaktsiin
Ishii et al. A novel immunogen selectively eliciting CD8+ T cells but not CD4+ T cells targeting immunodeficiency virus antigens
AR041515A1 (es) Vacuna a dna contra el virus de papiloma humano
CN101564533A (zh) 戊型肝炎蛋白-核酸复合疫苗及其制备方法
Shao et al. Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep
AR248047A1 (es) Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.
JP6708636B2 (ja) Bst2遺伝子の機能が喪失された細胞株を利用したウィルス感染促進及び産生増進方法
WO2019139648A3 (en) Dna antibody constructs for use against ebola virus
WO2000058444A3 (en) Adaptation of virus to vertebrate cells
WO2022011264A3 (en) Dna antibody constructs for use against rotavirus

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees